Cellasic Corporation

Hayward, CA 94545

SBIR Award Summary

Total Number of Awards 15
Total Value of Awards $4.71MM
First Award Date 05/25/06
Most Recent Award Date 01/01/12

Key Personnel

Last Name Name Awards Contact
Hung Paul Jusung Hung 8
Lee Philip J Lee 7

15 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-006
Budget: 01/01/12 - 12/31/12

DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead to the commercialization of a product with widespread application in the biopharmaceuti...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-114
Budget: 03/01/11 - 02/29/12

DESCRIPTION (provided by applicant): CellASIC has developed a novel microfluidic technology to integrate 32 bioreactors on a standard 96-well plate for multiplexed perfusion culture of primary human hepatocytes with demonstrated long-term viability and liver-enzymatic function. This Phase 1 SBIR will utilize this technology to develop and valid...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-006
Budget: 01/24/11 - 12/31/11

DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead to the commercialization of a product with widespread application in the biopharmaceuti...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-006
Budget: 05/18/10 - 11/30/10

DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead to the commercialization of a product with widespread application in the biopharmaceuti...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-07-041
Budget: 05/01/10 - 03/30/11

DESCRIPTION (provided by applicant): This Phase II SBIR proposes to develop a microfluidic cell culture and analysis platform for the in vitro screening of cancer cells. The end result of this research will be to deliver a fully functional system (automated instrument and disposable microfluidics) that can be used in both research and pharmaceut...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-114
Budget: 03/01/10 - 02/28/11

DESCRIPTION (provided by applicant): CellASIC has developed a novel microfluidic technology to integrate 32 bioreactors on a standard 96-well plate for multiplexed perfusion culture of primary human hepatocytes with demonstrated long-term viability and liver-enzymatic function. This Phase 1 SBIR will utilize this technology to develop and valid...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-019
Budget: 09/21/09 - 03/31/10

DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to commercialize the SBS standard format microfluidic bioreactor array developed in Phase I for high throughput physiologic cell-based screening in the pharmaceutical and biotechnology industry, with special focus on predictive hepatotoxicity screening, which has...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-07-041
Budget: 05/01/09 - 04/30/10

DESCRIPTION (provided by applicant): This Phase II SBIR proposes to develop a microfluidic cell culture and analysis platform for the in vitro screening of cancer cells. The end result of this research will be to deliver a fully functional system (automated instrument and disposable microfluidics) that can be used in both research and pharmaceut...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-019
Budget: 04/01/09 - 03/31/11

DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to commercialize the SBS standard format microfluidic bioreactor array developed in Phase I for high throughput physiologic cell-based screening in the pharmaceutical and biotechnology industry, with special focus on predictive hepatotoxicity screening, which has...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-07-41
Budget: 05/12/08 - 04/30/09

DESCRIPTION (provided by applicant): This Phase II SBIR proposes to develop a microfluidic cell culture and analysis platform for the in vitro screening of cancer cells. The end result of this research will be to deliver a fully functional system (automated instrument and disposable microfluidics) that can be used in both research and pharmaceut...

Load More